Related Experiment Video
Updated: Jan 28, 2026

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
Published on: May 10, 2020
Gene delivery methods and genome editing of human pluripotent stem cells
Patrycja Czerwińska1,2, Sylwia Mazurek1,2,3, Iga Kołodziejczak2
1Laboratory of Gene Therapy, Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland.
Abstract:
Induced pluripotent stem cells derived from normal somatic cells could be utilized to study tumorigenesis through overexpression of specific oncogenes, downregulation of tumor suppressors and dysregulation of other factors thought to promote tumorigenesis. Therefore, effective approaches that provide direct modifications of induced pluripotent stem cell genome are extremely needed. Emerging strategies are expected to provide the ability to more effectively introduce diverse genetic alterations, from as small as single-nucleotide modifications to whole gene amplification or deletion, all with a high degree of target specificity. To date, several techniques have been applied in stem cell studies to directly edit cell genome (ZFNs, TALENs or CRISPR/Cas9). In this review, we summarize specific gene delivery strategies that were applied to stem cell studies together with genome editing techniques, which enable a direct modification of endogenous DNA sequences in the context of cancer studies.
Insights
Induced pluripotent stem cells offer a powerful model for cancer research. Genome editing techniques like CRISPR/Cas9 enable precise genetic modifications for studying tumorigenesis.
Area of Science:
- Stem cell biology
- Cancer research
- Molecular genetics
Background:
- Induced pluripotent stem cells (iPSCs) derived from somatic cells are valuable tools for studying cancer development.
- Understanding tumorigenesis requires precise genetic manipulation of iPSCs.
- Current methods for iPSC genome modification are being advanced.
Purpose of the Study:
- To review gene delivery strategies for iPSC genome editing.
- To highlight techniques enabling direct modification of endogenous DNA in iPSCs for cancer studies.
Main Methods:
- Review of existing literature on gene delivery and genome editing in stem cells.
- Focus on techniques such as Zinc-Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and CRISPR/Cas9.
- Analysis of strategies for introducing genetic alterations (single nucleotide modifications, gene amplification/deletion).
Main Results:
- Various gene delivery methods have been applied to stem cell studies.
- Genome editing techniques allow for targeted DNA modification in iPSCs.
- These approaches facilitate the study of genetic factors in tumorigenesis.
Conclusions:
- Effective genome editing strategies are crucial for iPSC-based cancer research.
- Emerging techniques offer high specificity for diverse genetic alterations.
- Direct DNA modification in iPSCs is key to advancing cancer studies.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Genome Size and the Evolution of New Genes
Genome Size and the Evolution of New Genes
CRISPR/Cas9 Genome Editing
Genomics

